Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$8,150,913
+$296,568 QoQ
Shares Held
32,094
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.17%
of 13F equity value
Holder Rank
#1,232
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. JNJ ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
|
4,053 | $212,458 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,150,913 | 32,094 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $7,854,345 | 32,132 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $6,780,302 | 32,763 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $6,400,326 | 34,518 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $5,276,596 | 34,544 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $5,757,301 | 34,716 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $4,988,088 | 34,491 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $5,575,998 | 34,407 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $5,094,114 | 34,853 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $5,473,215 | 34,599 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $5,039,347 | 32,151 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $5,010,166 | 32,168 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $5,322,461 | 32,156 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $5,045,250 | 32,550 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $5,667,108 | 32,081 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $5,434,660 | 33,268 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $5,883,923 | 33,147 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $5,878,541 | 33,169 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $5,581,500 | 32,627 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $5,218,065 | 32,310 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $5,320,607 | 32,297 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $5,209,401 | 31,697 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $4,976,512 | 31,621 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $4,644,609 | 31,197 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $4,378,233 | 31,133 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,917,377 | 29,874 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||